Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01769248 | Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle(MUCIN) | completed | N/A | 140 | Northwestern UniversityOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01781520 | Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 47 | Capital Medical UniversityOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02459041 | Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes(ADVEUS) | completed | — | 100 | University of Medicine and Pharmacy CraiovaOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01677559 | Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies | completed | Phase 1 | 34 | Washington University School of MedicineOTHER | 1 | Jan 11, 2018 | clinicaltrials |
| NCT00033241 | Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | — | OSI PharmaceuticalsINDUSTRY | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. | completed | Phase 3 | 569 | OSI PharmaceuticalsINDUSTRY | 17 | Jan 10, 2018 | clinicaltrials |
| NCT00810719 | Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | completed | Phase 2 | 30 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT01234935 | Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | completed | Phase 2 | 8 | Translational Oncology Research InternationalOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01589328 | Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB(EPADE-PB) | completed | N/A | 288 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 3, 2018 | clinicaltrials |
| NCT01146054 | Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma | completed | Phase 2 | 59 | Stanford UniversityOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT00290693 | Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer | completed | Phase 2 | 45 | University of MiamiOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00201838 | Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 38 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 30, 2017 | clinicaltrials |
| NCT00620295 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 16 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00667082 | NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma | completed | Phase 1 | 22 | CelgeneINDUSTRY | 1 | Nov 22, 2017 | clinicaltrials |
| NCT01430052 | Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Osaka Medical Center for Cancer and Cardiovascular DiseasesOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT02272738 | A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer | completed | Phase 1 | 54 | Osaka Medical Center for Cancer and Cardiovascular DiseasesOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01392027 | Biospecimens for Identification of Diseases of the Pancreas.(SPORE-PANC) | completed | N/A | 712 | University of MichiganOTHER | 1 | Nov 8, 2017 | clinicaltrials |
| NCT01836237 | The Use of Wound Protector in Whipple's Procedure With Intrabiliary Stent | completed | N/A | 107 | University of CalgaryOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT00383760 | Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2017 | clinicaltrials |
| NCT03302637 | Oral Microbiome and Pancreatic Cancer | completed | — | 732 | NYU Langone HealthOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00584363 | Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection(SPORE) | completed | — | 731 | University of Alabama at BirminghamOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT02920944 | Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions | completed | N/A | 35 | Seung Bae YoonOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT02241187 | Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection | completed | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT02017015 | Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer(PANC-001) | completed | Phase 2 | 83 | CelgeneINDUSTRY | 1 | Sep 26, 2017 | clinicaltrials |
| NCT02486497 | Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining | completed | N/A | 40 | Seoul National University HospitalOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01897415 | Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer | completed | Phase 1 | 16 | University of PennsylvaniaOTHER | 1 | Sep 19, 2017 | clinicaltrials |
| NCT00900016 | Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery | completed | — | 37 | Fox Chase Cancer CenterOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT00763516 | Proton Radiation for Resectable Carcinoma of the Pancreas(PC02) | completed | N/A | 8 | University of FloridaOTHER | 1 | Sep 6, 2017 | clinicaltrials |
| NCT01553019 | Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer(PC03) | completed | Phase 2 | 2 | University of FloridaOTHER | 1 | Sep 6, 2017 | clinicaltrials |
| NCT01150630 | Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer(PACT-15) | completed | Phase 2 | 98 | IRCCS San RaffaeleOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01730222 | A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma(PACT-19) | completed | Phase 1 / Phase 2 | 137 | IRCCS San RaffaeleOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer(FOLFIRINOX) | completed | Phase 2 | 75 | Yale UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01770405 | Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract(US-nCLE) | completed | — | 40 | Mauna Kea TechnologiesINDUSTRY | 1 | Aug 29, 2017 | clinicaltrials |
| NCT00685763 | Proton Therapy for Unresectable Cancer (CA) of Pancreas(PC01) | completed | N/A | 13 | University of FloridaOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT01693419 | S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | completed | Phase 2 | 37 | Hallym University Medical CenterOTHER | 1 | Aug 23, 2017 | clinicaltrials |
| NCT01783171 | Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 2 | Aug 22, 2017 | clinicaltrials |
| NCT00288093 | 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Aug 18, 2017 | clinicaltrials |
| NCT01764477 | Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma | completed | Phase 1 | 20 | Prism Pharma Co., Ltd.INDUSTRY | 1 | Aug 17, 2017 | clinicaltrials |
| NCT01383538 | FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | completed | Phase 1 | 15 | Andrew KoOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT01195415 | Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Aug 7, 2017 | clinicaltrials |
| NCT01040000 | QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer | completed | Phase 1 / Phase 2 | 94 | Precision Biologics, IncINDUSTRY | 1 | Aug 4, 2017 | clinicaltrials |
| NCT01809028 | Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions | completed | N/A | 62 | AdventHealthOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT01815606 | Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm | completed | N/A | 51 | AdventHealthOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT01191684 | Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer | completed | Phase 1 | 12 | City of Hope Medical CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01303029 | Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer(GECA) | completed | Phase 2 | 120 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02080650 | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00920023 | Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) | completed | Phase 4 | 35 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2018source: clinicaltrials